WST logo

West Pharmaceutical Services, Inc. Stock Price

NYSE:WST Community·US$19.6b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 19 Fair Values set on narratives written by author

WST Share Price Performance

US$272.56
-23.94 (-8.07%)
13.8% undervalued intrinsic discount
US$316.36
Fair Value
US$272.56
-23.94 (-8.07%)
13.8% undervalued intrinsic discount
US$316.36
Fair Value
Price US$272.56
AnalystConsensusTarget US$316.36

WST Community Narratives

AnalystConsensusTarget·Updated
Fair Value US$316.36 13.8% undervalued intrinsic discount

HVP Automation And GLP-1 Demand Will Strengthen Future Position

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative

Recent WST News & Updates

West Pharmaceutical Services, Inc.'s (NYSE:WST) Shares Climb 25% But Its Business Is Yet to Catch Up

Jul 25
West Pharmaceutical Services, Inc.'s (NYSE:WST) Shares Climb 25% But Its Business Is Yet to Catch Up

Here's Why West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt Responsibly

Jul 13
Here's Why West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt Responsibly

West Pharmaceutical Services, Inc. Key Details

US$3.0b

Revenue

US$1.9b

Cost of Revenue

US$1.0b

Gross Profit

US$556.4m

Other Expenses

US$487.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
6.78
Gross Margin
35.27%
Net Profit Margin
16.48%
Debt/Equity Ratio
6.9%

West Pharmaceutical Services, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with questionable track record.

0 Risks
1 Reward

About WST

Founded
1923
Employees
10600
CEO
Eric Green
WebsiteView website
www.westpharma.com

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 1.2%
  • 3 Months: 7.7%
  • 1 Year: 17.9%
  • Year to Date: 14.9%
Over the last 7 days, the market has risen 1.2%, driven by gains of 2.4% in the Information Technology sector. The market is up 18% over the last 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›